









Markets
/
Stocks
/
nasdaq-ctor
/

Citius Oncology Inc

CTOR

1.365USD

-0.025-1.80%

Market hours （ET）Quotes delayed by 15 min

97.67MMarket Cap

LossP/E TTM



Citius Oncology Inc

1.365

-0.025-1.80%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Citius Oncology Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

--0.00

412.72%684.15K

100.00%0.00

-356.09%-218.78K

---113.47K

---100.26K

---168.80K

---47.97K

Net income from continuing operations

---5.37M

-59.97%-7.74M

-40.86%-6.66M

-744.44%-6.66M

-884.61%-4.84M

-872.80%-4.73M

171.35%1.03M

--157.94K

--616.30K

--611.73K

--380.81K

Deferred tax

--264.24K

83.50%264.24K

--264.24K

--144.00K

----

Change in working capital

--2.98M

96.84%5.38M

72.01%4.59M

-31133.58%-7.87M

2653.88%2.73M

12871.96%2.67M

-60.52%25.36K

--307.98K

--99.30K

---20.88K

--64.24K

-Change in inventory

---1.87M

---957.88K

---6.11M

----

-Change in prepaid expenses

--1.60M

----

--0.00

-3369.32%-1.08M

-3632.22%-1.17M

100.00%0.00

137.63%33.18K

--33.18K

---36.82K

---88.17K

-Change in other current liabilities

----

--126.42K

Cash from non-recurring investing activities

Cash from operating activities

--0.00

412.72%684.15K

100.00%0.00

-356.09%-218.78K

---113.47K

---100.26K

---168.80K

---47.97K

Investing cash flow

Net cash flow from investment products

----

-3658.70%-24.81M

--68.64K

--24.74M

99.02%-660.00K

---660.00K

----

---67.32M

Net cash flow from other investing activities

----

---5.00M

----

Cash from non-current investing activities

Net cash flow from investing activities

----

-4416.28%-29.81M

--0.00

99.02%-660.00K

---660.00K

----

---67.32M

Financing cash flow

Cash flow from continuous financing activities

----

3194.45%29.16M

-100.00%0.00

--0.00

-98.69%885.00K

--429.90K

--349.98K

----

--67.66M

Net cash flow from debt Issuance/repayment

----

2027.44%28.08M

--325.31K

--200.00K

1110.05%1.32M

----

---130.69K

Net cash flow from common stock issuance/repurchase

----

---268.64K

---24.94M

----

--66.03M

Net cash flow from other financing activities

----

346.82%1.07M

--207.73K

--192.27K

-124.68%-435.00K

--429.90K

----

--1.76M

Net cash from non-recurrent financing activities

Net cash from financing activities

----

3194.45%29.16M

-100.00%0.00

--0.00

-98.69%885.00K

--429.90K

--349.98K

----

--67.66M

Net cash flow

Beginning cash balance

--112.00

--0.00

--112.00

-222.48%-32.48K

-100.00%0.00

--26.52K

--370.10K

--120.38K

--289.18K

--0.00

Current period cash flow changes

--0.00

423.81%32.60K

-100.00%0.00

100.00%0.00

-97.85%6.22K

---343.57K

--249.72K

---168.80K

--289.18K

Ending cash balance

--112.00

--0.00

--112.00

-99.66%112.00

-100.00%0.00

-88.68%32.75K

--26.52K

--370.10K

--120.38K

--289.18K

Free cash flow

----

412.72%684.15K

---366.11K

---191.69K

-356.09%-218.78K

---113.47K

----

---47.97K

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

